Abstract
Introduction
Breast sentinel lymph node biopsy (SLNB) evaluates if cancer has spread outside the breast, by allowing the identification of the node that has the highest probability of harboring metastastis. Once it is identified and removed during surgery, histologic examination looks for the presence of metastasis. If metastasis are identified, the patient will have an axillary dissection performed, if no metastasis are identified, the patient can spare the axillary dissection with its associated morbility. SLNB procedures are performed with radiotracers or with dyes, or a combination of both. Recently, the hybrid tracer (fluorescent-radioactive) 99mTc nanocolloid indocyanine green (99mTc NC ICG) has been described. The aim of our work is to describe our experience with the hybrid tracer in breast SLN biopsy. Materials Patients were inyected periareolary subcutaneous in the same cuadrant of the lesions. Planar Scintigraphic and SPECT/CT (Mediso Anyscan) images were later acquired. During the SLNB a gamma probe (Europrobe) and our own developed near infrared (NIR) visualization system was used to localize the SLN. This combination allowed surgeons to guide them to the SLN using the acoustic cue provided from the gamma probe and the images from the NIR visualization system. Once the nodes were found they were removed and examined histopathologically. Patients who had positive SLNB underwent axillary dissection.
Results
SLNB with 99mTc NC ICG allowed us to use their complementary fluorescent and radioactive properties in order to find the SLN. In this way, the gamma probe guided us to the region where the node was, and fluorescence made it easy to remove it and spare the rest of surrounding tissue. In this way we could remove 38 nodes, being 4 positive. All radioactive nodes where fluorescent.
Conclusions
SLNB with 99mTc NC ICG could be performed without complications, having no adverse effects on patients. The hybrid tracer adds a visual cue with to the procedure aiding surgeons on SLN localization and removal.
Breast sentinel lymph node biopsy (SLNB) evaluates if cancer has spread outside the breast, by allowing the identification of the node that has the highest probability of harboring metastastis. Once it is identified and removed during surgery, histologic examination looks for the presence of metastasis. If metastasis are identified, the patient will have an axillary dissection performed, if no metastasis are identified, the patient can spare the axillary dissection with its associated morbility. SLNB procedures are performed with radiotracers or with dyes, or a combination of both. Recently, the hybrid tracer (fluorescent-radioactive) 99mTc nanocolloid indocyanine green (99mTc NC ICG) has been described. The aim of our work is to describe our experience with the hybrid tracer in breast SLN biopsy. Materials Patients were inyected periareolary subcutaneous in the same cuadrant of the lesions. Planar Scintigraphic and SPECT/CT (Mediso Anyscan) images were later acquired. During the SLNB a gamma probe (Europrobe) and our own developed near infrared (NIR) visualization system was used to localize the SLN. This combination allowed surgeons to guide them to the SLN using the acoustic cue provided from the gamma probe and the images from the NIR visualization system. Once the nodes were found they were removed and examined histopathologically. Patients who had positive SLNB underwent axillary dissection.
Results
SLNB with 99mTc NC ICG allowed us to use their complementary fluorescent and radioactive properties in order to find the SLN. In this way, the gamma probe guided us to the region where the node was, and fluorescence made it easy to remove it and spare the rest of surrounding tissue. In this way we could remove 38 nodes, being 4 positive. All radioactive nodes where fluorescent.
Conclusions
SLNB with 99mTc NC ICG could be performed without complications, having no adverse effects on patients. The hybrid tracer adds a visual cue with to the procedure aiding surgeons on SLN localization and removal.
| Original language | English |
|---|---|
| Article number | 1231 |
| Journal | The Journal of Nuclear Medicine |
| Volume | 60 |
| Issue number | Supplement 1 |
| Publication status | Published - 1 May 2019 |
